HUE063622T2 - Azonnali hatóanyagleadású, állandó dózisú memantin és donezepil kombináció - Google Patents

Azonnali hatóanyagleadású, állandó dózisú memantin és donezepil kombináció

Info

Publication number
HUE063622T2
HUE063622T2 HUE20732664A HUE20732664A HUE063622T2 HU E063622 T2 HUE063622 T2 HU E063622T2 HU E20732664 A HUE20732664 A HU E20732664A HU E20732664 A HUE20732664 A HU E20732664A HU E063622 T2 HUE063622 T2 HU E063622T2
Authority
HU
Hungary
Prior art keywords
memantine
donepezil
immediate release
dose combination
release fixed
Prior art date
Application number
HUE20732664A
Other languages
English (en)
Inventor
Machuco Estevens Maria Catarina Oliveira
Marques Da Costa Ricardo Manuel Silva
Serra Joâo Pedro Silva
Filipe Augusto Eugenio Pardal
Original Assignee
Tecnimede Soc Tecnico Medicinal Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Soc Tecnico Medicinal Sa filed Critical Tecnimede Soc Tecnico Medicinal Sa
Publication of HUE063622T2 publication Critical patent/HUE063622T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE20732664A 2019-05-31 2020-05-29 Azonnali hatóanyagleadású, állandó dózisú memantin és donezepil kombináció HUE063622T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT2019115557 2019-05-31

Publications (1)

Publication Number Publication Date
HUE063622T2 true HUE063622T2 (hu) 2024-01-28

Family

ID=88650785

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE20732664A HUE063622T2 (hu) 2019-05-31 2020-05-29 Azonnali hatóanyagleadású, állandó dózisú memantin és donezepil kombináció

Country Status (6)

Country Link
ES (1) ES2960207T3 (hu)
HU (1) HUE063622T2 (hu)
LT (1) LT3843702T (hu)
MA (1) MA53513B1 (hu)
PL (1) PL3843702T3 (hu)
RS (1) RS64694B1 (hu)

Also Published As

Publication number Publication date
MA53513B1 (fr) 2023-10-31
PL3843702T4 (pl) 2024-04-08
ES2960207T3 (es) 2024-03-01
MA53513A (fr) 2021-09-08
PL3843702T3 (pl) 2024-04-08
LT3843702T (lt) 2023-11-10
RS64694B1 (sr) 2023-11-30

Similar Documents

Publication Publication Date Title
IL284835A (en) Pharmaceutical combination containing TNO155 and ribociclib
IL257015B (en) Pharmaceutical combination of 2mdm inhibitor and 2bcl inhibitor
EP3578204A4 (en) BIOACTIVE SUBSTANCE CONJUGATE WITH ENHANCED DURABILITY AND ITS USE
IL269236A (en) Engineered amphiphilic antimicrobial peptides and methods of use
IL288372A (en) Modified release preparation and uses thereof
GB201812339D0 (en) Reconcilliation of run-time and configuration discrepancies
SG10202113199RA (en) Dementia therapeutic agent combining pyrazoloquinoline derivative and memantine
IL277129A (en) Human papillomavirus vaccines and their uses
EP3448362A4 (en) EXTENDED RELEASE FORMULATION AND USE THEREOF
GB2574954B (en) Tissue scaffold and scaffold composition
GB2615479B (en) Therapeutic and prophylactic use of microoganisms
IL288505A (en) Immediate release in a fixed dose of memantine and donepezil
PL3843702T3 (pl) Natychmiastowo uwalniana kombinacja memantyny i donepezilu o ustalonej dawce
ZA201905343B (en) Antiseptic composition comprising polyvinylpyrrolidone and unithiol and use of the composition
SG10202108219QA (en) Prophylactic and/or therapeutic agent of infectious disease or inflammatory disease
IL291543A (en) Medical preparations and their use
IL277441A (en) Variants of LFA3 and their preparations and uses
EP3373907A4 (en) EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE
EP3727347A4 (en) LONG-RELEASE MIDODRINE HYDROCHLORIDE COMPOSITIONS AND METHODS OF USE
GB201913456D0 (en) Polymer-comprising medical devices and uses thereof
PT3664800T (pt) Formulações terapêuticas que compreendem inibidor da cox-2 e utilizações das mesmas
EP3730138A4 (en) DRUG CONTAINING A COMBINATION OF SEPETAPROST AND RHO-KINASE INHIBITOR
IL292646A (en) Pharmaceutical combination and its use
EP3888636A4 (en) EUTECTIC DONEPEZI MIX AND USE THEREOF
GB202313260D0 (en) Modified release formulation comprising withanolides